Fny Investment Advisers, LLC Seagen Inc. Transaction History

Fny Investment Advisers, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 10, 2023	BUY	$191.51 - $216.16 $4.47 Million - $5.05 Million	23,366 Added 195.79%	35,300 $7.49 Million
Q2 2023 Jul 11, 2023	BUY	$187.64 - $206.25 $1.41 Million - $1.55 Million	7,514 Added 170.0%	11,934 $2.3 Million
Q1 2023 Apr 12, 2023	BUY	$127.59 - $203.08 $563,947 - $897,613	4,420 New	4,420 $894,000
Q1 2021 Apr 12, 2021	SELL	$137.51 - $190.8 $38,915 - $53,996	-283 Closed	0 $0
Q4 2020 Jan 19, 2021	BUY	$164.63 - $211.93 $46,590 - $59,976	283 New	283 $49,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.